Financial statements Bioarcus
Balance sheet data of BIOARCUS
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 2 313 479,15 | 2 500 781,23 | 3 227 854,38 | 4 494 827,65 | 4 593 176,21 | 5 619 214,64 |
A. Fixed assets | 82 139,51 | 40 983,63 | 163 752,13 | 166 350,09 | 235 814,89 | 198 569,25 |
B. Current assets | 2 231 339,64 | 2 459 797,60 | 3 064 102,25 | 4 328 477,56 | 4 357 361,32 | 5 420 645,39 |
C. Share capital contributions (basic funds) | - | - | - | - | 0,00 | - |
D. Own shares (stocks) | - | - | - | - | 0,00 | - |
Total liabilities | 2 313 479,15 | 2 500 781,23 | 3 227 854,38 | 4 494 827,65 | 4 593 176,21 | 5 619 214,64 |
A. Equity | 574 574,35 | 591 285,66 | 931 820,27 | 1 352 250,11 | 1 707 007,49 | 2 322 170,89 |
B. Liabilities and provisions for liabilities | 1 738 904,80 | 1 909 495,57 | 2 296 034,11 | 3 142 577,54 | 2 886 168,72 | 3 297 043,75 |
I. Long-term liabilities | 410 000,00 | 975 170,00 | 1 280 000,00 | 1 250 000,00 | 1 256 131,19 | 996 130,70 |
II. Short-term liabilities | 1 326 280,20 | 923 757,24 | 1 001 684,11 | 1 448 609,53 | 1 145 087,50 | 2 017 445,68 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.